Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) EBT Margin (2016 - 2025)

Perspective Therapeutics' EBT Margin history spans 15 years, with the latest figure at 13624.76% for Q4 2024.

  • For Q4 2024, EBT Margin fell 1296517.0% year-over-year to 13624.76%; the TTM value through Sep 2025 reached 35170.36%, down 3532361.0%, while the annual FY2024 figure was 5689.12%, N/A changed from the prior year.
  • EBT Margin for Q4 2024 was 13624.76% at Perspective Therapeutics, down from 5040.67% in the prior quarter.
  • Across five years, EBT Margin topped out at 11.72% in Q4 2021 and bottomed at 13624.76% in Q4 2024.
  • The 5-year median for EBT Margin is 136.73% (2022), against an average of 1460.08%.
  • The largest annual shift saw EBT Margin surged 4851bps in 2021 before it plummeted -1296517bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 36.8% in 2020, then surged by 132bps to 11.72% in 2021, then plummeted by -2122bps to 236.92% in 2022, then crashed by -178bps to 659.59% in 2023, then crashed by -1966bps to 13624.76% in 2024.
  • Per Business Quant, the three most recent readings for CATX's EBT Margin are 13624.76% (Q4 2024), 5040.67% (Q3 2024), and 2229.42% (Q2 2024).